Log in

OTCMKTS:BIOQBIOQUAL Stock Price, Forecast & News

0.00 (0.00 %)
(As of 07/10/2020 04:00 PM ET)
Today's Range
Now: $66.50
50-Day Range
MA: $66.21
52-Week Range
Now: $66.50
Average Volume156 shs
Market Capitalization$59.19 million
P/E Ratio14.49
Dividend Yield1.05%
Bioqual, Inc. provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases. Its services also include sample processing, virus stock generation, infectious virus quantitation, virus neutralization assays, hemagglutination inhibition assays, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.97 out of 5 stars

Industry, Sector and Symbol

Industry Commercial physical research
Current SymbolOTCMKTS:BIOQ



Sales & Book Value

Annual Sales$39.48 million
Cash Flow$4.14 per share
Book Value$27.46 per share


Net Income$2.83 million


Market Cap$59.19 million
Next Earnings Date9/11/2020 (Estimated)
OptionableNot Optionable

Receive BIOQ News and Ratings via Email

Sign-up to receive the latest news and ratings for BIOQ and its competitors with MarketBeat's FREE daily newsletter.

BIOQUAL (OTCMKTS:BIOQ) Frequently Asked Questions

How has BIOQUAL's stock been impacted by COVID-19 (Coronavirus)?

BIOQUAL's stock was trading at $51.75 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BIOQ shares have increased by 28.5% and is now trading at $66.50. View which stocks have been most impacted by Coronavirus.

When is BIOQUAL's next earnings date?

BIOQUAL is scheduled to release its next quarterly earnings announcement on Friday, September 11th 2020. View our earnings forecast for BIOQUAL.

How were BIOQUAL's earnings last quarter?

BIOQUAL, Inc. (OTCMKTS:BIOQ) issued its quarterly earnings results on Tuesday, April, 21st. The company reported $0.81 EPS for the quarter. The business earned $11.59 million during the quarter. BIOQUAL had a return on equity of 16.16% and a net margin of 9.23%. View BIOQUAL's earnings history.

How often does BIOQUAL pay dividends? What is the dividend yield for BIOQUAL?

BIOQUAL declared an annual dividend on Friday, September 13th. Investors of record on Wednesday, September 25th will be paid a dividend of $0.70 per share on Wednesday, October 16th. This represents a dividend yield of 2%. The ex-dividend date is Tuesday, September 24th. This is a boost from BIOQUAL's previous annual dividend of $0.60. View BIOQUAL's dividend history.

Has BIOQUAL been receiving favorable news coverage?

Press coverage about BIOQ stock has trended neutral on Sunday, according to InfoTrie. The research firm scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. BIOQUAL earned a coverage optimism score of 0.4 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news about BIOQUAL.

Who are some of BIOQUAL's key competitors?

Who are BIOQUAL's key executives?

BIOQUAL's management team includes the following people:
  • Dr. David A. Newcomer, Chief Financial Officer (Age 58)
  • Dr. Marisa St. Claire DVM, VP - Primate Biology and Medicine (Age 54)
  • Dr. Mark G. Lewis, Chairman, CEO & Pres (Age 64)
  • Mitch Franklin, Chief Operating Officer
  • Nancy A. Madden, VP of Admin. Operations & Biosafety Officer

What is BIOQUAL's stock symbol?

BIOQUAL trades on the OTCMKTS under the ticker symbol "BIOQ."

How do I buy shares of BIOQUAL?

Shares of BIOQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is BIOQUAL's stock price today?

One share of BIOQ stock can currently be purchased for approximately $66.50.

How big of a company is BIOQUAL?

BIOQUAL has a market capitalization of $59.19 million and generates $39.48 million in revenue each year.

What is BIOQUAL's official website?

The official website for BIOQUAL is www.bioqual.com.

How can I contact BIOQUAL?

BIOQUAL's mailing address is 9600 Medical Center Drive Suite 101, ROCKVILLE MD, 20850. The company can be reached via phone at 240-404-7654 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.